1. Introduction {#sec1-molecules-23-00758}
===============

Herb processing of herbal medicines, including the special crafts of steaming, baking, decocting, and other methods with liquid or solid Supplementary Materials, plays an important role in the application of traditional Chinese medicine (TCM). There is a close relationship between processing, quality, and efficacy of herbal medicines. The discrimination between raw and processed herbal medicines is a basic and important task for the investigation of the mechanism of herb processing and the quality control (QC) of herbs.

Radix *Achyranthis bidentatae* (RAB), derived from the dried roots of *Achyranthes bidentata* Bl., has been used in traditional Chinese medicines for nourishing the liver and kidney, strengthening bones and tendons, promoting diuresis, relieving dysuria and promoting blood circulation \[[@B1-molecules-23-00758],[@B2-molecules-23-00758],[@B3-molecules-23-00758],[@B4-molecules-23-00758],[@B5-molecules-23-00758],[@B6-molecules-23-00758],[@B7-molecules-23-00758],[@B8-molecules-23-00758],[@B9-molecules-23-00758],[@B10-molecules-23-00758]\]. Generally, TCM should be processed before clinical use. RAB has been used in three forms in TCM: one is raw RAB (RRAB), while the other two are processed with the wine and salt method, which is called wine RAB (WRAB) and salt RAB (SRAB), respectively. According to the "Shen Nong's Herbal Classic" records, RAB needs to be processed before clinical use in helping the kidney and strengthening bones, muscles, and tendons. Particularly, after being processed with salt, the promotion of blood circulation and restoration of bone fractures will be strengthened \[[@B11-molecules-23-00758],[@B12-molecules-23-00758]\]. Several types of chemical analytes, particularly phytoecdysones and triterpenoid saponins, have been identified from the roots of RAB \[[@B13-molecules-23-00758],[@B14-molecules-23-00758],[@B15-molecules-23-00758],[@B16-molecules-23-00758],[@B17-molecules-23-00758],[@B18-molecules-23-00758],[@B19-molecules-23-00758],[@B20-molecules-23-00758]\]. Lei et al. \[[@B21-molecules-23-00758]\] showed that *β*-ecdysterone prevented the process of osteoporosis. Gao et al. \[[@B22-molecules-23-00758]\] demonstrated that *β*-ecdysterone promoted the proliferation of osteoid cells UMR106. Dong et al. \[[@B2-molecules-23-00758]\] revealed its effects on treatment of osteoporosis in ovariectomized rats. Yu et al. \[[@B6-molecules-23-00758]\] demonstrated that triterpenoidal saponins could inhibit osteoclast formation and thus, could be used as bone resorption inhibitors to treat osteoporosis. Guo et al. \[[@B8-molecules-23-00758]\] suggested that *Achyranthes bidentata* Saponins (ABS) stimulated osteogenic differentiation of bone mesenchymal stem cells (BMSCs) via activation of the extracellular regulated protein kinases (ERK) signaling pathway. Ren et al. \[[@B23-molecules-23-00758],[@B24-molecules-23-00758]\] demonstrated that ABS improved bone metabolism of osteoporosis induced by retinoic acid in rats. Therefore, RAB was used for nourishing liver and kidney as well as strengthening bones and tendons due to the interaction of multiple components. However, for raw, wine-processed, and salt-processed RAB, it is well known that a single marker compound (*β*-ecdysterone) might not accurately reflect the intrinsic quality control and response for the overall pharmacological activities of the complex herbal product. Thus, it is necessary to develop a reliable method for simultaneous quantification of five bioactive analytes, including *β*-ecdysterone, 25-S inokosterone, 25-R inokosterone, ginsenoside R~0~, and chikusetsusaponin Iva, for quality control of raw, wine-processed, and salt-processed RAB.

Various studies \[[@B25-molecules-23-00758],[@B26-molecules-23-00758],[@B27-molecules-23-00758]\] have focused on the phytoecdysones and triterpenoid saponins of RAB using high performance liquid chromatography (HPLC) with diode array detection and UHPLC coupled with evaporative light scattering detector (ELSD). However, the methods resulted in waste solvent, long analysis time, and poor selectivity with only retention time through the identification of chromatographic peaks, which was generally not adequate for the analysis of herbal samples characterized by the complex matrix. Although some methods based on HPLC have been reported for the determination of several of these components in RAB, there is still no method established for the simultaneous determination of the phytoecdysones and triterpenoid saponins using UHPLC--MS/MS. Furthermore, no report is available on comparative studies of the processing methods for these analytes. The UHPLC--MS/MS technique has the advantages of abundant mass fragmentations and many scan modes afforded by tandem mass spectrometry, which can provide the required specificity and sensitivity as well as decrease separation time and solvent consumption. Therefore, this method is appropriate for simultaneous determination of the polarity differences of the two types of target analytes and the existence of isomers (*β*-ecdysterone, 25-R inokosterone, and 25-S inokosterone).

The traditional uses of RAB have been largely expanded upon. Experimental studies indicate that RAB possesses a number of pharmacological activities, including anti-tumor \[[@B28-molecules-23-00758]\], immunostimulant \[[@B29-molecules-23-00758],[@B30-molecules-23-00758]\], anti-fertility \[[@B31-molecules-23-00758],[@B32-molecules-23-00758]\], anti-bacterial \[[@B33-molecules-23-00758]\], anti-inflammatory \[[@B34-molecules-23-00758]\], cognition-enhancing \[[@B35-molecules-23-00758]\], anti-senile \[[@B36-molecules-23-00758],[@B37-molecules-23-00758]\], antioxidant \[[@B38-molecules-23-00758],[@B39-molecules-23-00758]\], and anti-osteoporosis \[[@B40-molecules-23-00758],[@B24-molecules-23-00758],[@B2-molecules-23-00758]\] properties. In terms of treatment, RAB has been used to influence carbohydrate metabolism in the blood \[[@B41-molecules-23-00758],[@B42-molecules-23-00758]\], hasten growth \[[@B43-molecules-23-00758]\], and improve the dual modulatory function of the immune system \[[@B44-molecules-23-00758],[@B45-molecules-23-00758]\]. Therefore, RAB has received considerable critical attention. However, our research has shown differences in the content of different batches of Chinese medicine from the Henan Province. This might be due to some factors, such as intrinsic factors, including plant region and genetic variation, and extrinsic factors, including the season (different climatic), geography (soil and minerals conditions), harvest time, storage conditions, and environmental pollution \[[@B46-molecules-23-00758],[@B47-molecules-23-00758],[@B48-molecules-23-00758]\]. To explore these complex factors of RAB, UHPLC-MS/MS combined with chemometric tools is the preferred method of sample comparison for quality assessment requirements. This method is increasingly important in the quality assessment of herbal medicines.

In this study, an UHPLC--MS/MS method was established for simultaneous quantification of five bioactive analytes, including *β*-ecdysterone, 25-R inokosterone, 25-S inokosterone, ginsenoside R~0~, and chikusetsusaponin IVa in raw, wine-processed, and salt-processed RAB. The validated method was applied to evaluate the quality of the samples from different batches and processed methods, before the results were further analyzed by hierarchical clustering analysis (HCA), principal component analysis (PCA), heat map, and boxplot analysis to provide more information about the differences in each sample.

2. Results {#sec2-molecules-23-00758}
==========

2.1. Optimization of Extraction Conditions {#sec2dot1-molecules-23-00758}
------------------------------------------

Three parameters, including extraction time (30, 40, 60, and 80 min), solvent volume (25, 50, and 75 mL) and extraction solvent (25, 50, 75, and 100% methanol/water), which may prejudice the extraction efficiency of ultrasonication, were optimized using univariate analytes. The extraction rates of the five major analytes were gradually increased as the extraction time was increased from 10 to 80 min. Further increases in the extraction time did not increase the extraction rates of the five major analytes. Thus, 60 min was adequate for the extraction procedure. Secondly, the effect of solvent volume was of great importance for the extraction procedure. When solvent volume was increased from 25 to 50 mL, the extraction rates of the five major analytes gradually increased. When the solvent volume was increased to 75 mL, the extraction rates of the five major analytes decreased. This phenomenon may be due to the dilution effect exceeding the hydrotropic effect of increased solvent. Thus, 50 mL of solvent volume was enough for the extraction of the five major analytes. Thirdly, the solvent ratio between methanol and water that may also bias the methanol ratio was increased from 25, 50, 75, and 100%. The largest extraction rates of the five major analytes were achieved by using a solvent ratio of 50% ([Figure S1](#app1-molecules-23-00758){ref-type="app"}). Finally, the optimal conditions for the extraction procedure were as follows: solvent volume of 50 mL; extraction time of 60 min; and solvent ratio of 50% methanol/water.

2.2. Optimization of Chromatographic and Mass Spectrometric Conditions {#sec2dot2-molecules-23-00758}
----------------------------------------------------------------------

Two types of analytes (phytoecdysones and triterpenoid saponins) differ greatly due to their structural features. This is especially the case for the rapid and complete separation of polar phytoecdysones isomers (i.e., *β*-ecdysterone, 25-R inokosterone, and 25-S inokosterone), which have the same *m*/*z* for the precursor and product ions. Hence, mobile phase selection is critical in separating these analytes properly. To achieve optimal separation and peak shape without excessive peak tailing in a short analysis time, the chromatographic conditions, such as mobile phase, solvent modifier, and gradient program, were optimized in the preliminary test. For *β*-ecdysterone, 25-R inokosterone, 25-S inokosterone, ginsenoside R~0~, and chikusetsusaponin Iva, an acetonitrile/water mobile phase system yielded better signal intensity than that of methanol/water. Simultaneously, different concentrations (0.1%, 0.3%, and 0.5%) of acetic acid were checked to optimize ionization. Moreover, the signal intensities of the analytes were investigated by adding acetic acid to the water phase. The addition of 0.3% acetic acid significantly increased the signal intensity of the five analytes, especially for the acetonitrile/water system. Meanwhile, the addition of 0.3% acetic acid was beneficial to the peak shape of the analytes. Satisfactory separation was achieved after 10 min by gradient elution using an acetonitrile/water (0.3% acetic acid) system at a flow rate of 0.3 mL/min. The reference compound of each analyte was directly infused into the mass spectrometer (MS) along with the mobile phase to optimize the MS conditions. The mass responses of the five analytes in both positive and negative modes were investigated, with a better response obtained in the negative ionization mode. Throughout the development of the method, the selectivity, reproducibility, and robustness of the MS method were monitored and adjusted to establish methods that could be validated and applied. The following multiple reaction monitoring modes were found to be specific and intense ([Figure 1](#molecules-23-00758-f001){ref-type="fig"}) for the analysis of *β*-ecdysterone (*m*/*z* 479.519→319.0), ginsenoside R~0~ (*m*/*z* 955.745→793.5), chikusetsusaponin IVa (*m*/*z* 793.678→631.4), and glycyrrhizin (IS) (*m*/*z* 255.207→119.0). The details are presented in [Table 1](#molecules-23-00758-t001){ref-type="table"} and [Figure 2](#molecules-23-00758-f002){ref-type="fig"}.

2.3. Method Validation {#sec2dot3-molecules-23-00758}
----------------------

The proposed UHPLC--MS/MS approach for quantitative analysis was validated by determining the linearity, limit of detection (LOD), limit of quantity (LOQ), intra-day and inter-day precisions, stability, repeatability, and accuracy. The results are summarized in [Table 2](#molecules-23-00758-t002){ref-type="table"} and [Table 3](#molecules-23-00758-t003){ref-type="table"}. The method had a good linear range and the results determined were accurate and reliable. The LOD and LOQ were in the range of 0.325--0.499 and 0.955--1.485 mg/mL, respectively. The overall intra-day and inter-day variations (RSDs) were in the range of 1.57--2.46 and 1.51--3.00%, respectively. The repeatability and stability presented as RSD were in the range of 2.16--3.00 and 2.54--2.97%, respectively. The overall recoveries were 98.58--101.48% with RSDs of 0.01--1.86%. These results indicated that the developed UHPLC--MS/MS approach was sensitive, repeatable and accurate for the quantitative analysis of the five analytes.

2.4. Quantitative Analysis and Boxplot Analysis of Raw, Wine-Processed, and Salt-Processed Products {#sec2dot4-molecules-23-00758}
---------------------------------------------------------------------------------------------------

RAB is one of the ancient and frequently used herbal medicines in both Eastern and Western countries, with its use dates back more than 2000 years. In TCM, RAB is usually processed and traditionally used to reinforce the muscles and bones, improve the tone of liver and kidneys and promote blood flow. *β*-ecdysterone, 25-R inokosterone, 25-S inokosterone, ginsenoside R~0~, and chikusetsusaponin IVa are the main components of the curative effect of the RAB. Therefore, it is necessary to develop a reliable method for simultaneous quantification of *β*-ecdysterone, 25-R inokosterone, 25-S inokosterone, ginsenoside R~0~, and chikusetsusaponin IVa. The newly developed UHPLC--MS/MS approach was employed for simultaneous quantification of five analytes, including *β*-ecdysterone, 25-R inokosterone, 25-S inokosterone, ginsenoside R~0~, and chikusetsusaponin IVa, in 21 batches of raw, wine-processed, and salt-processed products from different regions of the Henan Province. The quantitative analyses were performed by means of the internal standard method. Each sample was extracted and analyzed, with the analytical results summarized in [Table 4](#molecules-23-00758-t004){ref-type="table"}. The study found that there were large variations in the contents of the five major analytes in different batches of raw, wine-processed, and salt-processed samples. The results proved that the content of salt-processed RAB is better than that of raw products. The highest content of *β*-ecdysterone was obtained in each sample, followed by ginsenoside R~0~ and chikusetsusaponin IVa. In addition, there are differences in the content of different batches of Chinese medicine from the Henan Province. Therefore, we need to measure these five major analytes to control the quality of the RAB. Meanwhile, salt-processed RAB samples had the highest content of analytes extracted from RAB, which was shown through UHPLC--MS/MS analysis. According to the theories of TCM and the results of this study, the treatment effects of salt-processed RAB are better than that of raw products due to the increase in content of the active ingredients.

In this work, boxplot analysis was employed to evaluate the quality of 21 batches through the data distribution of five target analytes. The content of five target analytes in raw, wine-processed, and salt-processed products is shown in [Figure 3](#molecules-23-00758-f003){ref-type="fig"}. From the boxplots, it is clear that *β*-ecdysterone, 25-S inokosterone, 25-R inokosterone, ginsenoside R~0~, and chikusetsusaponin IVa have higher concentrations in salt-processed samples. Otherwise, the most important finding was the content of salt-processed RAB being better than that of raw and wine-processed RAB. It has become necessary to develop a reliable method for simultaneous determination of the concentration of five target analytes, including *β*-ecdysterone, 25-S inokosterone, 25-R inokosterone, ginsenoside R~0~, and chikusetsusaponin IVa, in raw, wine-processed, and salt-processed for quality control of RAB.

2.5. Chemometric Analysis {#sec2dot5-molecules-23-00758}
-------------------------

### 2.5.1. Hierarchical Clustering Analysis {#sec2dot5dot1-molecules-23-00758}

Hierarchical clustering analysis (HCA) is a statistical method for finding relatively homogeneous sample groups based on selected characteristics. The approach has been widely used for species authentication, origin discrimination, and quality evaluation of traditional Chinese medicines \[[@B49-molecules-23-00758],[@B50-molecules-23-00758]\]. To analyze the samples from Henan, the data from 21 batches of raw RAB were imported into the MultiExperiment Viewer (MeV) software (Dana-Farber Cancer Institute, Boston, MA, USA). Trends with regards to the relative concentrations of the target analytes in the samples were visualized using a heat map. As shown in [Figure 4](#molecules-23-00758-f004){ref-type="fig"}, the analytes content of the samples exhibited a red color on the heat map, indicating that these samples contained different levels of the five analytes. From green to red, the heat map colors represent the relative content of the five analytes in all the assessed samples. The red represents the relative highest content. With the green color deepening, the relative content decreased. First, S6 are distinctly different in Heshan, which is the reason for the maximum content of *β*-ecdysterone and reduced content of triterpenoid saponins. Secondly, it was evident that the other RAB samples were clearly clustered into two groups: I (Zhengzhou, Luoyang, Kaifeng, Nanyang, Zhoukou, Jinshui, Longting, Gulou, Lankao, and Xiangfu) and II (Qinyang, Wushe, Wenxian, Xiayi, Mengxian, Boai, Macun, Jiefang, and Shanyang Hongqi). This means that the five major analytes were significantly different in different RABs. As shown in [Figure 4](#molecules-23-00758-f004){ref-type="fig"}, the total content of the phytoecdysones and triterpenoid saponins in Group II had a red color on the heat map, indicating that II group samples contained higher levels of the analytes and were of better quality medicinal materials compared with the samples from other regions. These differences are probably due to some factors, such as intrinsic factors, including plant origin and genetic variation, and extrinsic factors, including the season (different climatic), geography (soil and minerals conditions), harvest time, storage conditions, and environmental pollution. Finally, the information from [Table 4](#molecules-23-00758-t004){ref-type="table"} shows that there is different content in different batches of Chinese medicine from the Henan Province. These all suggested that each collection procedure should be standardized in the future to ensure the quality of RAB.

### 2.5.2. Principal Component Analysis {#sec2dot5dot2-molecules-23-00758}

Principal component analysis (PCA) is a widely used method that provides an interpretable overview of the main information in numerical datasets in a multivariate space \[[@B51-molecules-23-00758]\]. To analyze the differences between the raw, wine-processed, and salt-processed groups, the data from the three groups were imported into the SIMCA-P 13 software package. The concentrations of the RRAB, WRAB, and SRAB were calculated in the three-dimensional space. According to the three dimensional (3D) score plots ([Figure 5](#molecules-23-00758-f005){ref-type="fig"}), RRAB, WRAB, and SRAB were reasonably well separated on the 3D coordinates for the three different processed methods with dramatic differences between them, indicating that variations in the chemical content of the three different processed methods were remarkable. The samples from the different processed methods were classified into three sub-clusters by PCA. These results suggested that RRAB, WRAB, and SRAB may possess different qualities, efficacies and indications. The analysis of five major analytes was suitable for the quality control of RAB.

In fact, the importance of the chemometric method has been highlighted based on their wide use in the quality control of herbal medicines \[[@B52-molecules-23-00758],[@B53-molecules-23-00758],[@B54-molecules-23-00758]\]. In this study, PCA coupled with boxplots indicated that the processing methods result in significant differences in quality and illustrated that the salt and wine-processed RAB significantly alters chemical components compared to the raw RAB. These two methods play an important role and combined with UHPLC-MS/MS, the PCA analytical approaches can be used to discriminate different plant origin, productive processes, cultivation pattern, and other factors that may affect the quality of RAB. This method can enhance the quality evaluation of RAB and ensure efficacious and safe use, which can provide a completely new way for quick and accurate analyses of herbal medicines.

3. Materials and Methods {#sec3-molecules-23-00758}
========================

3.1. Chemicals and Reagents {#sec3dot1-molecules-23-00758}
---------------------------

HPLC grade acetonitrile was obtained from Thermo Fisher Scientific, America. HPLC grade acetic acid was obtained from Dimka Pure (Richmond Hill, NY, USA). Other reagent solutions and chemicals were of analytical grade. Chemical standards of *β*-ecdysterone, ginsenoside R~0~, chikusetsusaponin IVa and glycyrrhizin (IS) were obtained from Chengdu Must Bio-Technology Co., Ltd., Chengdu, China. For this study, 25-R inokosterone and 25-S inokosterone were isolated and identified from the roots of RAB by our laboratory. The purity of each compound was more than 98%, which was determined by HPLC analysis.

Twenty-one batches of RAB were collected from different regions of Henan Province. The wine-processing procedure and salt-processing procedure were performed according to the 0213 general rules of processing in Chinese pharmacopeia 2015 edition. The botanical origins of the plants were identified as RAB by Prof. Lianjie Su and the voucher specimens (accession number, PC2012216019) were deposited at Heilongjiang University of Chinese Medicine, Harbin, China.

3.2. Preparation of Sample Solutions {#sec3dot2-molecules-23-00758}
------------------------------------

All the RAB samples were pulverized and sieved (60 mesh). A total of 0.5 g of the powdered sample was immersed into a methanol/water solvent in a flask, before being ultrasonicated in a water bath. Three parameters were investigated to optimize the extraction conditions. Different solvent volumes (25, 50, and 75 mL), (30, 40, 60, and 80 min) and extraction solvent (25, 50, 75, and 100% methanol/water) were employed for optimization of the extraction rates. An aliquot (5 μL) of the supernatant solution was injected into UHPLC--MS/MS for analysis.

3.3. UHPLC--MS/MS Analysis Conditions {#sec3dot3-molecules-23-00758}
-------------------------------------

Chromatographic analysis was performed in an ultra-high performance liquid chromatography (Thermo Scientific^TM^, Vanquish^TM^, (Waltham, MA, USA), using a Thermo Hypersil GOLD (Waltham, MA, USA) C~18~ column (100 mm × 2.1 mm, 1.9 μm). The column temperature was maintained at 35 °C. The mobile phase was composed of acetonitrile and water (both containing 0.3% acetic acid), with a gradient elution: 0--6 min and 83% water; 6--8 min and 5--84% water; and 8--10 min and 5% water. The flow rate of the mobile phase was 0.3 mL/min, while the injection volume was 5 μL.

Mass spectrometric detection was carried out using a Thermo TSQ QUANTIS triple quadrupole mass spectrometer using electron spray ionization (ESI) source operated in negative ion mode. The parameters in the source were set as follows: sheath gas of 40 Arb; aux gas of 10 Arb; ion transfer tube temp of 325 °C; and vaporizer temperature of 350 °C.

3.4. Validation of the Method {#sec3dot4-molecules-23-00758}
-----------------------------

For calibration, the linearity was used to describe the relationship of the analyte concentrations and detector response based on peak area ratio of analytes to IS. The lowest concentration of the working solution for calibration use was diluted with methanol/water to a series of appropriate concentrations. Fresh calibration standards were prepared for each day of analysis during the validation. LOD and LOQ were determined at a signal-to-noise ratio (S/N) of about 3 and 10, respectively. The precision was evaluated by analyzing the standard solutions containing the five standard analytes six times. For intra-day variability test, the individual sample solution was analyzed six times within one day (*n* = 6), while the inter-day reproducibility was determined with six individual sample solutions for three consecutive days (*n* = 6). To confirm the repeatability, six different sample solutions prepared from the same sample (sample 5) were analyzed and variations were expressed by RSD. For stability investigation, one of the sample solutions mentioned above was stored at 25 °C and analyzed at 0, 4, 8, 16, 32, and 48 h. A recovery test was used to evaluate the accuracy of this method. The spiked samples were subsequently extracted, processed and quantified in accordance with the methods mentioned above. The extraction recoveries of the analytes were investigated at three QC levels. Briefly, the sample was spiked with known amounts of the standard analytes at low, medium and high concentrations for the five analytes. These were thoroughly mixed, before being extracted and analyzed under optimized conditions. The average recoveries were calculated by the formulae: recovery (%) = (amount found−original amount)/amount spiked × 100% and RSD (%) = (SD/mean) × 100%.

3.5. Qualitative and Quantitative Analysis {#sec3dot5-molecules-23-00758}
------------------------------------------

The identification of five major analytes (*β*-ecdysterone, 25-R inokosterone, 25-S inokosterone, ginsenoside R~0~ and chikusetsusaponin IVa) was carried out by comparing the UHPLC retention time of target peaks and the characteristics of their protonated ions with those of the standards by UHPLC--MS/MS in negative ion mode. Quantification was performed by plotting the peak-area ratio of the five analytes to IS against their concentrations.

3.6. Applications for Different Batches of Raw, Wine-Processed, and Salt-Processed Products {#sec3dot6-molecules-23-00758}
-------------------------------------------------------------------------------------------

The established UHPLC--MS/MS approach was applied for the simultaneous quantification of *β*-ecdysterone, 25-R inokosterone, 25-S inokosterone, ginsenoside R~0~ and chikusetsusaponin IVa in 21 batches of raw, wine-processed, and salt-processed products. The contents of the five analytes in 21 different batches of raw, wine-processed, and salt-processed RAB were determined.

3.7. Data Processing {#sec3dot7-molecules-23-00758}
--------------------

All the experiments were performed at least in triplicate with constant results. Differences among groups were considered significant at *p* \< 0.05. The heat map and HCA were made using MultiExperiment Viewer (MeV) software (Dana-Farber Cancer Institute, Boston, MA, USA) with z-score normalization. Principal component analysis (PCA) was performed by SIMCA 13.0 software (Umetrics, Umeå, Sweden). The boxplot were charted by Origin 8 (OriginLab, Northampton, MA, USA).

4. Conclusions {#sec4-molecules-23-00758}
==============

In this work, a simple, sensitive and reliable UHPLC-MS/MS method for simultaneous quantification of five analytes in 21 batches of raw, wine-processed, and salt-processed RAB was developed and validated. The study suggested that a combination of UHPLC-MS/MS and chemometric methods could discriminate raw, wine-processed, and salt-processed samples under different processing conditions. The results of this study proved that the content of salt-processed RAB is better than that of raw products and wine-processed products. Notably, the bioactive analytes after salt-processing will contribute to the reinforcement of liver and kidney nourishment. The results show that the study provides a theoretical basis for the salt-processed RAB nourishing liver and kidney and strengthening bones and tendons. In summary, this study has established an efficient analytical method for the quality control of RAB and has also provided a valuable reference for the quality assessment of other herbal medicines.
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![Representative MS/MS spectra of glycyrrhizin (IS) (**A**), *β*-ecdysterone, 25-R inokosterone, 25-S inokosterone, (**B**) ginsenoside R~0~ (**C**), and chikusetsusaponin IVa (**D**). Among them, there are isomers (*β*-ecdysterone, 25-R inokosterone, and 25-S inokosterone) that have the same *m*/*z* for the precursor and product ions, which only showed the MS/MS spectra of *β*-ecdysterone.](molecules-23-00758-g001){#molecules-23-00758-f001}

![Total ion chromatogram with time scanning of glycyrrhizin (IS) (**A**), *β*-ecdysterone (**B1**), 25-R inokosterone (**B2**), 25-S inokosterone (**B3**), chikusetsusaponin IVa (**C**), and ginsenoside R~0~ (**D**).](molecules-23-00758-g002){#molecules-23-00758-f002}

![Boxplots of the five target analytes of 21 batches in raw, wine-processed, and salt-processed samples RAB. The **A**--**E** in the figure represents the five major analytes in raw, wine-processed, and salt-processed RAB, including: *β*-ecdysterone (**A**); 25-S inokosterone (**B**); 25-R inokosterone (**C**); ginsenoside R~0~ (**D**); and chikusetsusaponin IVa (**E**). Compared with raw samples, \* *p* \< 0.05, \*\* *p* \< 0.01; the middle line in the boxplot represents the median.](molecules-23-00758-g003){#molecules-23-00758-f003}

![Heat map of the relative concentrations of the five major analytes in all the assessed samples. The S1--21 in the figure represents the samples of different regions of Henan Province. The numbers of 1--5 in the figure represents the five major analytes, including *β*-ecdysterone (1); 25-S inokosterone (2); 25-R inokosterone (3); ginsenoside R~0~ (4); and chikusetsusaponin IVa (5).](molecules-23-00758-g004){#molecules-23-00758-f004}

![Three-dimensional principal component analysis (PCA) plots in 21 batches of raw RAB (RRAB), wine RAB (WRAB), and salt RAB (SRAB). Letters on the figure denote the processed type investigated: (R) RRAB, (W) WRAB, and (S) SRAB.](molecules-23-00758-g005){#molecules-23-00758-f005}

molecules-23-00758-t001_Table 1

###### 

Precursor/product ion pairs and parameters for selected reaction monitoring (SRM) of the five analytes and internal standard.

  Analytes                t~R~ (min)   \[M − H\]^−^   SRM Transitions (Precursor→Product)   Collision Energy (eV)
  ----------------------- ------------ -------------- ------------------------------------- -----------------------
  *β-*ecdysterone         2.85         479.519        479.519→319.0                         28.54
  25-R inokosterone       3.24         479.519        479.519→319.0                         28.54
  25-S inokosterone       3.52         479.519        479.519→319.0                         28.54
  ginsenoside R~0~        8.65         955.745        955.745→793.5                         55.00
  chikusetsusaponin IVa   8.75         793.678        793.678→631.4                         47.04
  glycyrrhizin (I.S.)     8.52         255.207        255.207→119.0                         25.43

molecules-23-00758-t002_Table 2

###### 

Calibration curves, correlation coefficients, linearity ranges, limit of detection (LOD) and limit of quantity (LOQ) data of the five investigated analytes.

  Analytes                Calibration Curves     r^2^     Linearity Ranges (mg/mL)   LOD (mg/mL)   LOQ (mg/mL)
  ----------------------- ---------------------- -------- -------------------------- ------------- -------------
  *β-*ecdysterone         y = 0.0545x − 0.0558   0.9993   1.90--494.0                0.365         1.085
  25-S inokosterone       y = 0.3174x − 0.3118   0.9995   1.35--270.0                0.332         0.995
  25-R inokosterone       y = 0.3814x − 0.5633   0.9993   1.75--315.0                0.499         1.485
  ginsenoside R~0~        y = 0.4588x − 0.4343   0.9994   2.10--210.0                0.325         0.955
  Chikusetsusaponin IVa   y = 0.6858x − 0.7556   0.9994   1.85--185.0                0.369         1.105

molecules-23-00758-t003_Table 3

###### 

Precision, repeatability, stability, and recovery of the five investigated analytes (overall intra-day and inter-day variations (RSD), %, *n* = 6).

  Analytes                Precision   Repeatability   Stability   Recovery (%, mean/RSD, *n* = 3)                                   
  ----------------------- ----------- --------------- ----------- --------------------------------- --------------- --------------- ---------------
  *β-*ecdysterone         1.57        2.25            2.95        2.68                              98.91 (0.01)    99.31 (0.07)    99.29 (0.07)
  25-S inokosterone       2.46        1.51            2.25        2.54                              98.98 (0.47)    101.17 (0.85)   98.58 (1.86)
  25-R inokosterone       1.83        1.72            2.58        2.97                              101.48 (0.14)   98.68 (0.42)    99.81 (0.90)
  ginsenoside R~0~        2.34        1.68            2.16        2.58                              101.09 (0.28)   100.57 (0.72)   100.89 (0.15)
  Chikusetsusaponin IVa   1.78        3.00            3.00        2.63                              101.41 (0.23)   99.75 (0.84)    99.97 (0.78)
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###### 

Contents of five analytes in 21 batches of raw, wine-processed, and salt-processed samples.

  No.   Region or Pharmacy (Specimen No.)   Content of Investigated Components (*n* = 3, mg/g ± SD)                                                                                                                                                                                                                          
  ----- ----------------------------------- --------------------------------------------------------- ---------------- ---------------- --------------- --------------- ---------------- --------------- --------------- ---------------- ---------------- ---------------- ---------------- --------------- --------------- ----------------
  S1    Wenxian, Henan (NWH2016-01)         12.778 ± 0.318                                            31.214 ± 0.198   88.051 ± 0.410   0.636 ± 0.006   1.453 ± 2.545   4.667 ± 0.791    0.880 ± 0.009   1.935 ± 0.025   6.153 ± 0.084    0.740 ± 0.024    4.396 ± 0.020    11.221 ± 0.009   0.956 ± 0.010   2.943 ± 0.001   13.864 ± 0.226
  S2    Zhengzhou, Henan (NZH2016-02)       26.493 ± 0.167                                            32.577 ± 0.002   81.066 ± 0.387   1.153 ± 0.034   1.477 ± 0.001   4.117 ± 0.097    1.458 ± 0.019   1.897 ± 0.029   41.570 ± 0.716   0.400 ± 0.002    3.880 ± 0.024    12.268 ± 0.068   0.444 ± 0.002   1.905 ± 0.007   13.608 ± 0.448
  S3    Zhoukou, Henan (NZH2016-03)         38.670 ± 0.194                                            38.554 ± 0.002   81.746 ± 0.335   1.680 ± 0.002   1.798 ± 0.073   4.417 ± 0.030    2.216 ± 0.016   2.308 ± 0.003   5.852 ± 0.011    2.232 ± 0.002    3.033 ± 0.076    9.5488 ± 0.006   1.319 ± 0.002   1.784 ± 0.003   12.519 ± 0.019
  S4    Jiefang, Henan (NJH2016-04)         23.406 ± 0.123                                            30.819 ± 0.017   50.605 ± 0.404   1.083 ± 0.002   1.423 ± 0.003   2.982 ± 0.560    1.437 ± 0.036   1.844 ± 0.003   3.979 ± 0.096    7.520 ± 0.005    5.866 ± 0.001    12.925 ± 0.108   3.250 ± 0.197   4.525 ± 0.014   16.179 ± 0.006
  S5    Wushe, Henan (NWH2016-05)           26.280 ± 0.262                                            35.231 ± 0.021   92.555 ± 0.613   1.141 ± 0.067   1.516 ± 0.003   4.677 ± 0.061    1.554 ± 0.002   2.045 ± 0.011   6.177 ± 0.085    6.108 ± 0.030    5.323 ± 0.023    11.986 ± 0.049   1.715 ± 0.001   3.131 ± 0.004   13.634 ± 0.017
  S6    Heshan, Henan (NHH2016-06)          14.076 ± 0.229                                            43.287 ± 0.025   77.559 ± 0.796   0.727 ± 0.004   1.948 ± 0.001   4.149 ± 0.014    0.986 ± 0.010   2.495 ± 0.001   5.545 ± 0/243    0.406 ± 0.002    0.580 ± 0.001    12.358 ± 0.383   0.483 ± 0.01    2.438 ± 0.002   13.716 ± 0.09
  S7    Jinshui, Henan (NJH2016-07)         11.332 ± 0.015                                            39.833 ± 0.020   70.805 ± 0.042   0.599 ± 0.013   1.754 ± 0.001   3.794 ± 0.018    0.812 ± 0.004   2.271 ± 0.003   4.892 ± 0.196    0.385 ± 0.005    3.604 ± 0.008    6.401 ± 0.054    0.504 ± 0.006   2.078 ± 0.017   6.0731 ± 0.022
  S8    Luoyang, Henan (NLH2016-08)         24.191 ± 0.036                                            36.948 ± 0.003   68.983 ± 0.428   1.115 ± 0.002   1.578 ± 0.004   3.789 ± 1.459    1.472 ± 0.003   2.035 ± 0.003   4.952 ± 0.144    6.654 ± 0.014    4.394 ± 0.001    13.239 ± 3.978   1.322 ± 0.008   2.544 ± 0.002   13.989 ± 0.004
  S9    Xiayi, Henan (NXH2016-09)           25.973 ± 0.215                                            35.182 ± 0.055   67.382 ± 0.603   1.230 ± 0.067   1.594 ± 0.002   29.085 ± 0.013   1.601 ± 0.006   1.984 ± 0.006   4.955 ± 0.049    12.930 ± 0.011   4.867 ± 0.023    22.730 ± 0.091   1.611 ± 0.007   3.099 ± 0.034   24.632 ± 0.006
  S10   Qinyang, Henan (NQH2016-10)         16.420 ± 0.106                                            4.202 ± 0.024    79.573 ± 0.177   0.806 ± 0.034   1.779 ± 0.001   4.242 ± 0.472    1.080 ± 0.002   2.354 ± 0.005   5.639 ± 0,.181   6.467 ± 0.108    9.142 ± 0.007    28.838 ± 0.164   2.272 ± 0.008   6.523 ± 0.034   30.468 ± 0.503
  S11   Kaifeng, Henan (NKH2016-11)         30.524 ± 0.013                                            21.687 ± 0.204   92.820 ± 0.568   1.397 ± 0.004   1.051 ± 0.001   4.966 ± 0.033    1.829 ± 0.004   1.359 ± 0.079   6.458 ± 0.035    4.089 ± 0.030    3.540 ± 0.042    4.935 ± 0.004    1.142 ± 0.002   1.616 ± 0.001   7.0181 ± 0.007
  S12   Lankao, Henan (NLH2016-12)          12.690 ± 0.101                                            37.268 ± 0.031   56.059 ± 0.068   0.646 ± 0.002   1.712 ± 0.057   3.267 ± 0.004    0.882 ± 0.001   2.208 ± 0.025   4.335 ± 0.019    1.310 ± 0.001    3.470 ± 0.004    16.011 ± 0.037   0.728 ± 0.001   1.656 ± 0.021   10.215 ± 0.016
  S13   Shanyang, Henan (NSH2016-13)        28.123 ± 0.053                                            29.411 ± 0.175   44.903 ± 0.086   1.255 ± 0.043   1.315 ± 0.001   2.648 ± 0.047    1.635 ± 0.001   1.715 ± 0.005   3.567 ± 0.109    10.360 ± 0.001   6.113 ± 0.001    6.812 ± 0.153    2.427 ± 0.010   4.202 ± 0.147   4.517 ± 0.07
  S14   Nanyang, Henan (NNH2016-14)         7.6519 ± 0.064                                            26.536 ± 0.157   68.005 ± 0.099   0.446 ± 0.006   1.173 ± 0.001   3.612 ± 0.581    0.621 ± 0.002   1.562 ± 0.008   4.790 ± 0.014    1.100 ± 0.001    4.006 ± 0.003    17.141 ± 0.070   0.700 ± 0.001   2.133 ± 0.024   8.525 ± 0.002
  S15   Macun, Henan (NMH2016-15)           16.737 ± 0.003                                            24.189 ± 0.034   78.139 ± 0.497   0.768 ± 0.014   1.057 ± 0.057   3.823 ± 0.289    1.078 ± 0.001   1.468 ± 0.010   5.214 ± 0.015    10.151 ± 0.08    7.249 ± 0.004    17.032 ± 0.052   2.862 ± 0.008   4.830 ± 0.007   16.423 ± 0.008
  S16   Longting, Henan (NLH2016-16)        23.450 ± 0.014                                            39.351 ± 0.050   59.081 ± 0.377   1.051 ± 0.015   1.726 ± 0.001   3.246 ± 0.003    1.414 ± 0.001   2.272 ± 0.014   4.353 ± 0.109    2.905 ± 0.135    4.513 ± 0.003    9.875 ± 0.227    1.212 ± 0.010   1.750 ± 0.006   3.0279 ± 0.001
  S17   Gulou, Henan (NGH2016-17)           15.539 ± 0.174                                            30.572 ± 0.003   67.816 ± 0.331   0.716 ± 0.003   1.279 ± 0.003   3.343 ± 0.001    0.995 ± 0.004   1.722 ± 0.09    4.628 ± 0.0119   2.034 ± 0.206    3.646 ± 0.006    5.127 ± 0.042    1.005 ± 0.001   1.253 ± 0.001   6.234 ± 0.029
  S18   Xiangfu, Henan (NXH2016-18)         30.854 ± 1.209                                            33.943 ± 0.003   96.379 ± 0.332   1.304 ± 0.003   1.513 ± 0.046   4.800 ± 0.020    1.768 ± 0.001   1.991 ± 0.006   6.297 ± 0.198    5.200 ± 0.147    3.600 ± 00.004   11.494 ± 0.029   1.797 ± 0.001   1.635 ± 0.004   5.432 ± 0.001
  S19   Mengxian, Henan (NMH2016-19)        22.038 ± 0.009                                            26.264 ± 0.013   83.783 ± 0.210   1.022 ± 0.015   1.159 ± 0.001   4.127 ± 0.272    1.343 ± 0.005   1.536 ± 0.004   5.558 ± 0.073    5.119 ± 0.040    3.545 ± 1.156    13.331 ± 0.006   2.164 ± 0.001   2.846 ± 0.005   10.735 ± 0.001
  S20   Boai, Henan (NBH2016-20)            10.088 ± 0.009                                            38.828 ± 0.003   86.465 ± 1.138   0.536 ± 0.002   1.695 ± 0.001   4.360 ± 0.023    0.743 ± 0.001   2.202 ± 0.086   5.632 ± 0.074    2.009 ± 0.011    5.517 ± 0.023    21.533 ± 0.012   1.157 ± 0.001   4.126 ± 0.015   15.114 ± 0.001
  S21   Hongqi, Henan (NHH2016-21)          18.976 ± 1.070                                            27.053 ± 0.020   35.614 ± 2.982   0.833 ± 0.020   1.141 ± 0.001   2.210 ± 0.083    1.152 ± 0.02    1.569 ± 0.012   3.121 ± 0.068    11.546 ± 0.037   6.552 ± 0.016    13.514 ± 0.001   3.277 ± 0.002   4.511 ± 0.179   8.721 ± 0.017

[^1]: These authors contributed equally to this work.
